Lexicon Pharmaceuticals Reaches Analyst Target Price
January 11, 2021 at 08:03 AM EST
In recent trading, shares of Lexicon Pharmaceuticals, Inc. (LXRX) have crossed above the average analyst 12-month target price of $3.75, changing hands for $3.84/share..